Coronavirus

Officials: Millions Of Orders Placed For COVID Vaccines For Youngest

White House officials say pharmacies and states have ordered 1.45 million Pfizer doses and about 850,000 Moderna shots.

President Joe Biden meets with COVID-19 Response Team
Andrew Harnik / AP
SMS

Millions of COVID-19 vaccine doses have been ordered for small children in anticipation of possible federal authorization next week, White House officials say.

The government allowed pharmacies and states to start placing orders last week, with 5 million doses initially available — half of them shots made by Pfizer and the other half the vaccine produced by Moderna, senior administration officials said.

FDA Advisers Back Novavax Vaccine As New U.S. Option
FDA Advisers Back Novavax Vaccine As New U.S. Option

FDA Advisers Back Novavax Vaccine As New U.S. Option

The hope is that Novavax will appeal to those who don't want an mRNA vaccine because trials showed it had fewer side effects.

LEARN MORE

As of this week, about 1.45 million of the 2.5 million available doses of Pfizer have been ordered, and about 850,000 of available Moderna shots have been ordered, officials said. More orders are expected in the coming days.

Young children are the last group of Americans who have not been recommended to get COVID-19 vaccinations. Up to about 20 million U.S. children under 5 would become eligible for vaccination if the government authorizes one or both shots.

It’s not clear how popular the shots will be. A recent survey suggests only 1 in 5 parents of young children would get their kids vaccinated right away.

And public health officials have been disappointed at how many older U.S. children, who have been eligible for shots for months, have yet to be vaccinated: Less than one-third of kids ages 5 to 11 have gotten the two recommended doses, according to government figures.

Pfizer has asked the FDA to authorize three doses of its COVID-19 vaccine for children ages 6 month to 4 years. Each dose is one-tenth of the amount adults receive.

Moderna has asked FDA to authorize two shots for kids ages 6 months to 5 years, each containing a quarter of the dose given to adults.

An FDA advisory committee is scheduled to meet Tuesday and Wednesday to review data from the two companies. Officials say they expect a FDA decision shortly after that meeting.

Additional reporting by The Associated Press.